跳至主要内容
临床试验/NCT02187614
NCT02187614已完成4 期

A Double Blind, Multi-arm Randomized Control Trial, for Efficacy of Intramuscular Diclofenac Versus Intravenous Morphine Versus Intravenous Paracetamol, in Renal Colic Emergency Department Pain Management

Hamad Medical Corporation1 个研究点 分布在 1 个国家目标入组 1,645 人开始时间: 2014年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
1,645
试验地点
1
主要终点
The proportion of patients achieving a reduction of >50% on Numerical Rating Scale (NRS-11) from the initial NRS recorded at the end of 30 minutes in each study arm.

研究概览

简要总结

Abdominal pain is one of the most common presentations to an emergency department (ED). Among patients presenting with abdominal pain, a common diagnosis in the Middle East is renal colic (urolithiasis or Kidney stones). As the patients with renal colic writhe around in agonizing pain, the first priority in an ED from a patient's perspective is fast and safe analgesia and to be pain free as early as possible. There are variations in physician preference to choose initial analgesic drug for managing such pain. Commonly used drugs are:

  • Opioids such as Morphine or Fentanyl
  • Non steroidal drugs such as Diclofenac, Ketorolac or Brufen
  • and Paracetamol intravenous injection.

A robust evidence in comparison of diclofenac versus morphine and paracetamol is lacking. This study is design to obtain data on efficacy of these three drugs within 30 minutes in a non inferiority trail.

详细描述

This will be a double blind RCT, where participants will be enrolled consecutively after meeting eligibility criteria and obtaining a written informed consent. They will be assign to one of the three study arms by computer generated randomization process. The study packets will be prepared by a dedicated nurse or pharmacist who will not a part of investigating team. Each Patients will receive one analgesic drug (active drug) and two placebos. Drugs will be given as one intramuscular injection and two intravenous solutions.

Pain score will be recorded using NRS at 0, 30, 60, and 90 minutes. Data will be collected on standard Data collection form. Each participant will receive analgesia from study packet which contains, one active drug and two placebos to be administer as one intramuscular and two intravenous solutions. At any given time every patient will receive one analgesia from either Diclofenac, Paracetamol or Morphine. If patient pain does not respond to initial treatments, at 30 minutes a rescue analgesia in form of morphine will be administered till patient is pain free or NRS<=2 or adverse event to morphine.

Based on the results of previous studies (1-3), proportion of patients achieving more than 50% pain reduction, is between 65-75% for diclofenac, morphine and paracetamol when compared with other drugs. In each group, 437 patients are required to detect a difference of 10% in primary outcome, in a superiority trial with power (1-beta) of 90% and significance level (alpha) of 5% in this study. Considering 15% extra, total sample size required in this superiority trial will be 1507 patients in total.

Data will be collected on a standard data recording form and it will be converted to electronic excel sheet hiding patient identifiable details. Continuous variables will be presented as mean with standard deviation (SD). Categorical variables will be calculated as proportions and presented with 95% Confidence interval (CI). Statistical analyses will be undertaken using Stata 12.0 (College Station, Texas).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >=18 years and < 65 years
  • Acute onset, one side flank or loin pain, with or without radiation to groin or genital areas.
  • Pain intensity on NRS more than or equal to
  • (Moderate to Severe Pain)
  • Diagnosis confirmed by non contrast CT KUB within the ED visit.

排除标准

  • Traumatic flank pain
  • Pregnancy
  • Known renal failure or impairment
  • Known allergy to morphine, diclofenac or paracetamol
  • Bronchial asthma
  • Previously enrolled in the study.
  • Use of any analgesia in last 6 hour.

研究组 & 干预措施

Diclofenac and Placebos

Experimental

Participants in this group will receive a Diclofenac 75 mg intramuscular injection, and two placebo saline solutions intravenously.

干预措施: Diclofenac (Drug)

Diclofenac and Placebos

Experimental

Participants in this group will receive a Diclofenac 75 mg intramuscular injection, and two placebo saline solutions intravenously.

干预措施: Placebos (Drug)

Morphine and Placebos

Active Comparator

Participants in this group will receive Morphine 0.1 mg/kg intravenously, along with an additional intravenous placebo and an intramuscular placebo injection.

干预措施: Morphine (Drug)

Morphine and Placebos

Active Comparator

Participants in this group will receive Morphine 0.1 mg/kg intravenously, along with an additional intravenous placebo and an intramuscular placebo injection.

干预措施: Placebos (Drug)

Paracetamol and Placebos

Active Comparator

participants in this group will receive intravenous Paracetamol 1 gm solution, along with an additional intravenous placebo and an intramuscular placebo injection.

干预措施: Paracetamol (Drug)

Paracetamol and Placebos

Active Comparator

participants in this group will receive intravenous Paracetamol 1 gm solution, along with an additional intravenous placebo and an intramuscular placebo injection.

干预措施: Placebos (Drug)

结局指标

主要结局

The proportion of patients achieving a reduction of >50% on Numerical Rating Scale (NRS-11) from the initial NRS recorded at the end of 30 minutes in each study arm.

时间窗: at 30 minutes after analgesia

次要结局

  • reduction in mean NRS(at 30, 60 and 90 minutes after analgesia)

研究者

申办方类型
Industry
责任方
Principal Investigator
主要研究者

Dr. SAMEER PATHAN

Research Fellow and Specialist

Hamad Medical Corporation

研究点 (1)

Loading locations...

相似试验